Aggravating influence of atomoxetine on the severity of stuttering and its successful treatment with methylphenidate: a case report
- 1 January 2020
- journal article
- research article
- Published by Kare Publishing in Dusunen Adam the Journal of Psychiatry and Neurological Sciences
- Vol. 33 (2), 210-213
- https://doi.org/10.14744/dajpns.2020.00081
Abstract
Stuttering is a communication disorder characterized by a disruption in normal fluency and time patterning of speech. None of the pharmacological agents for stuttering could be recommended for general use; specific drug treatment that is simultaneously effective for both stuttering and attention deficit hyperactivity disorder (ADHD) is currently unknown. In this article, we present a case affected by severe developmental stuttering and ADHD that was exacerbated by atomoxetine but favorably responded to treatment with methylphenidate. Kekemelik, konuşmanın normal akıcılığı ve zamanlama örüntüsünde bir aksaklık ile karakterize bir iletişim bozukluğudur. Kekemelikte hiçbir farmakolojik ajan genel kullanım için önerilmemiştir. Bu nedenle, hem kekemelik hem de dikkat eksikliği hiperaktivite bozukluğu için aynı anda etkili olan spesifik bir ilaç tedavisi şu anda bilinmemektedir. Bu makalede, atomoksetin ile şiddetlenen ancak metilfenidat tedavisine olumlu yanıt veren ciddi gelişimsel kekemelik ve dikkat eksikliği hiperaktivite bozukluğu olan bir olgu sunulmuştur.Keywords
This publication has 5 references indexed in Scilit:
- Emergence of stuttering in an attention deficit hyperactivity disorder patient treated with methylphenidateDusunen Adam the Journal of Psychiatry and Neurological Sciences, 2018
- Stuttering Associated With the Use of Short-Acting Oral MethylphenidateJournal of Clinical Psychopharmacology, 2015
- Influence of Methylphenidate on the Frequency of StutteringAnnals of Pharmacotherapy, 2015
- Traits of attention deficit/hyperactivity disorder in school-age children who stutterJournal of Fluency Disorders, 2012
- Alleviating stuttering with pharmacological interventionsExpert Opinion on Pharmacotherapy, 2004